Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

GT Pharma Pvt. Ltd

Private pharmaceutical manufacturer · Lahore · Pakistan

Lahore-based pharmaceutical manufacturer with a DRAP-listed GMP manufacturing facility at Sundar Industrial Estate.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence1 sourceCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
GT Pharma (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot No. 713, Sundar Industrial Estate, Lahore, Punjab, Pakistan
Corporate source details checked
16 Aug 2026
Corporate profile completeness
50%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000829 GT Pharma (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000829 47 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx49public portfolio records represented
REG41unique registrations represented
IDX47indexed MedInfoBase presentations
SRC1additional source-observed presentations
R+1registry-only registrations
VER1registry-verified exact registrations
PKR34current validated price records
G22generic molecules in indexed catalogue
DF6dosage-form groups
TA6therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage69%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage87%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixGT Pharma Pvt. LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/gt-pharma-pvt-ltdGenerated 24 Sep 2026Anti-infectives24 · 51%Gastrointestinal & hepatology10 · 21%Vitamins, minerals & nutrition7 · 15%Pain & musculoskeletal4 · 9%CNS & mental health1 · 2%Hematology & thrombosis1 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioGT Pharma Pvt. LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/gt-pharma-pvt-ltdGenerated 24 Sep 202647presentationsInjection17 · 36%Capsule11 · 23%Suspension10 · 21%Infusion6 · 13%Syrup2 · 4%Drops1 · 2%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionGT Pharma Pvt. LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/gt-pharma-pvt-ltdGenerated 24 Sep 202641comparable productsBelow peer median13 · 32%Near peer median14 · 34%Above peer median14 · 34%Company median price position+1.4%Lowest-price equivalents8Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsGT Pharma Pvt. LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/gt-pharma-pvt-ltdGenerated 24 Sep 2026M/s. Genix Pharma (Pvt) Ltd.16 shared73% overlapBio-Labs(Pvt) Ltd15 shared68% overlapMediate Pharmaceutical Pvt Ltd15 shared68% overlapNeutro Pharma (Pvt.) Ltd.,15 shared68% overlapPulse Pharmaceuticals (Pvt.) Ltd.15 shared68% overlapPharmasol (Pvt) Ltd.14 shared64% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives24 products · 51%
Gastrointestinal & hepatology10 products · 21%
Vitamins, minerals & nutrition7 products · 15%
Pain & musculoskeletal4 products · 9%
CNS & mental health1 products · 2%
Hematology & thrombosis1 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials7 products · 15%
Antiemetics6 products · 13%
Macrolide antibacterials5 products · 11%
Antifungals5 products · 11%
Antimalarials4 products · 9%
Proton pump inhibitors4 products · 9%
Vitamin K / haemostatic agents4 products · 9%
Analgesics / NSAIDs4 products · 9%
Formulation footprint

Dosage forms

Injection17 products
Capsule11 products
Suspension10 products
Infusion6 products
Syrup2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 GT ZoleFluconazole 4presentations 150 mg, 200 mg, 50 mg · Capsule #2 GT-SturtOndansetron 4presentations 4 mg/2 mL, 4 mg/5 mL, 8 mg/4 mL · Injection, Syrup #3 MizunaOmeprazole 3presentations 20 mg, 40 mg · Capsule #4 PersilDiclofenac 3presentations 75 mg/3 mL · Injection #5 ArtfulArtemether 2presentations 40 mg/mL, 80 mg/mL · Injection #6 ArtfulArtemether + Lumefantrine 2presentations 15 mg/5 mL + 90 mg/5 mL, 30 mg/5 mL + 180 mg/5 mL · Suspension
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1332% of comparable products
Near market median14within ±5% of median
Above market median1434% of comparable products
Lowest-price equivalents8ties included
Company median price position +1.4% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Ofbel 200 mg/100 mLOfloxacin · IV infusion · 1's PKR 194.15/vial/unit-32.3% vs market median GT-Sturt 4 mg/5 mLOndansetron · Syrup · 25ml PKR 14.13/mL-21.2% vs market median GT-Grit 150 mgIron polymaltose complex · Capsule · 30's PKR 18.98/capsule-17.8% vs market median Trebac 500 mg/100 mLLevofloxacin · IV infusion · 1's PKR 485.38/vial/unit-17.8% vs market median GT Cip 100ml 200 mg/100 mLCiprofloxacin · IV infusion · 1x100ml PKR 1.99/mL-13.4% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 16shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 15shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 15shared generics Neutro Pharma (Pvt.) Ltd.,210 products · 97 generics 15shared generics Pulse Pharmaceuticals (Pvt.) Ltd.116 products · 48 generics 15shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 14shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers39Distinct registrations among indexed, published, presentation-validated products only
Verified price observations47
Products with a verified price47
Products with multiple price observations0
Source records with multiple versions47
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

41 unique registration(s) · 47 indexed presentation(s) · 1 additional source-observed presentation(s) · 1 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Artful Artemether 80 mg/mL Injection 6'sx1ml 080672 PKR 1,196.82 PKR 199.47/mL 7% above median
Artful Artemether + Lumefantrine 15 mg/5 mL + 90 mg/5 mL Dry suspension 30ml 080681 PKR 179.52 PKR 5.98/mL 8% above median
Artful Artemether + Lumefantrine 30 mg/5 mL + 180 mg/5 mL Dry suspension 30ml 080682 PKR 299.20 PKR 9.97/mL No comparator
Artful Artemether 40 mg/mL Injection 10's 086376 PKR 1,196.82 PKR 119.68/vial/unit Near median
ED-3 1 ml Cholecalciferol 5 mg/mL Injection 1's 080881 PKR 226.58 PKR 226.58/vial/unit Near median
Estrum Esomeprazole 40 mg Injection 14's 096542 PKR 279.58 PKR 19.97/vial/unit 97% below median
Estrum 40mg InjectionRegistry verified Esomeprazole as sodium — — — 104924Official source ↗ No indexed price — —
G Azithro Azithromycin 250 mg Capsule 10's 080679 PKR 508.65 PKR 50.87/capsule Near median
G Azithro Dry Powder Azithromycin 200 mg/5 mL Suspension 15ml 103423 PKR 284.75 PKR 18.98/mL 13% below median
G Tant Aprepitant 80 mg Capsule 2's 080678 PKR 3,336.92 PKR 1,668.46/capsule 12% above median
G Tant Aprepitant 40 mg Capsule 2's 080880 PKR 1,998.03 PKR 999.02/capsule 12% above median
GT Cip Ciprofloxacin 125 mg/5 mL Suspension 60ml 080672 PKR 185.88 PKR 3.10/mL 12% below median
GT Cip 100ml Ciprofloxacin 200 mg/100 mL IV infusion 1x100ml 080676 PKR 199.47 PKR 1.99/mL 13% below median
GT Dol Haloperidol 5 mg/mL Injection 1ml x 25's 080674 PKR 329.13 PKR 13.17/mL No comparator
GT Gut Low Osmolarity ORSSource observed — — Sachet 20's 083185Official source ↗ No indexed price — —
GT Line Linezolid 200 mg/100 mL IV infusion 1'sx100ml 080879 PKR 690.17 PKR 6.90/mL Near median
GT Line Linezolid 600 mg/300 mL IV infusion 1's 095849 PKR 1,164.90 PKR 1,164.90/vial/unit 5% below median
GT Line Dry Powder Granules For Linezolid 100 mg/5 mL Suspension 60ml 083161 PKR 698.14 PKR 11.64/mL 6% above median
GT Mox Moxifloxacin 400 mg IV infusion 250mlx1's 080675 PKR 2,170.80 PKR 8.68/mL 18% above median
GT Mycim Clarithromycin 125 mg/5 mL Drops 25ml 093182 PKR 180.56 PKR 7.22/mL No comparator
GT Mycim granules for susp Clarithromycin 250 mg/5 mL Suspension 60ml 080683 PKR 736.04 PKR 12.27/mL Near median
GT Mycim granules for susp Clarithromycin 125 mg/5 mL Suspension 60ml 080685 PKR 444.82 PKR 7.41/mL Near median
GT Zole Fluconazole 150 mg Capsule 4's 080680 PKR 1,013.31 PKR 253.33/capsule Near median
GT Zole Fluconazole 150 mg Capsule 1's 080680 PKR 275.27 PKR 275.27/capsule Near median
GT Zole Fluconazole 50 mg Capsule 7's 092587 PKR 873.67 PKR 124.81/capsule Near median
GT Zole Fluconazole 200 mg Capsule 4's 096731 PKR 931.92 PKR 232.98/capsule 5% above median
GT Zole Dry Powder Fluconazole 50 mg/5 mL Suspension 35ml 080684 PKR 418.89 PKR 11.97/mL Near median
GT-CIP Dry Powder Ciprofloxacin 250 mg/5 mL Suspension 60ml 108446 PKR 276.12 PKR 4.60/mL 11% below median
GT-CIP Dry Powder Ciprofloxacin 500 mg/5 mL Suspension 30ml 108447 PKR 276.12 PKR 9.20/mL Near median
GT-Grit Iron polymaltose complex 150 mg Capsule 30's 108191 PKR 569.51 PKR 18.98/capsule 18% below median
GT-Sturt Ondansetron 4 mg/5 mL Syrup 25ml 108190 PKR 353.17 PKR 14.13/mL 21% below median
GT-Sturt Ondansetron 4 mg/5 mL Syrup 50ml 108190 PKR 862.89 PKR 17.26/mL Near median
GT-Sturt Ondansetron 8 mg/4 mL Injection 4mlx1's 108441 PKR 892.23 PKR 223.06/mL 11% below median
GT-Sturt Ondansetron 4 mg/2 mL Injection 2mlx1's 108442 PKR 664.43 PKR 332.22/mL 15% above median
K Lot Pediatric Phytomenadione 2 mg/1 mL Injection 5's 083184 PKR 721.07 PKR 144.21/vial/unit 10% below median
K Lot Pediatric Phytomenadione 2 mg/1 mL Injection 1's 083184 PKR 159.58 PKR 159.58/vial/unit 11% above median
K-LOT Phytomenadione 10 mg/mL Injection 5's 106359 PKR 1,254.45 PKR 250.89/vial/unit 76% above median
K-LOT Phytomenadione 10 mg/mL IV injection 1's 106359 PKR 277.63 PKR 277.63/vial/unit No comparator
Medisol Anticoagulant citrate dextrose solution Na citrate 2.20 g + Citric acid 0.73 g + Dextrose 2.20 g/100 mL Injection 2's 086437 PKR 5,211.35 PKR 2,605.68/vial/unit No comparator
Mizuna Omeprazole 40 mg Capsule 14's 096541 PKR 485.38 PKR 34.67/capsule Near median
Mizuna Omeprazole 20 mg Capsule 1's 096542 PKR 431.45 PKR 431.45/capsule 2,094% above median
Mizuna Omeprazole 40 mg Capsule 1's 104923 PKR 517.73 PKR 517.73/capsule 1,393% above median
Ofbel Ofloxacin 200 mg/100 mL IV infusion 1's 095848 PKR 194.15 PKR 194.15/vial/unit 32% below median
Persil Diclofenac 75 mg/3 mL IV injection 25's 095844 PKR 710.94 PKR 28.44/vial/unit Near median
Persil Diclofenac 75 mg/3 mL IV injection 5's 095844 PKR 126.20 PKR 25.24/vial/unit 12% below median
Persil Diclofenac 75 mg/3 mL IV injection 10's 095844 PKR 289.91 PKR 28.99/vial/unit 8% above median
Pyrenol Paracetamol 1000 mg/100 mL Injection 100ml 115205 PKR 157.45 PKR 1.57/mL No comparator
Surfer Iron sucrose 100 mg/5 mL Injection 5mlx5's 095843 PKR 2,863.71 PKR 114.55/mL 40% above median
Trebac Levofloxacin 500 mg/100 mL IV infusion 1's 096693 PKR 485.38 PKR 485.38/vial/unit 18% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). GT Pharma Pvt. Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/gt-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.